Food prices, which have contributed to a large part of inflation over recent years, have remained benign, despite unseasonal rain.
The management, however, is a bit wary about near-term performance.
Stocks and sectors impacted most by GST.
RBI projects GDP growth in FY16 at 7.8 per cent, 30 bps higher than FY15. However, this comes with a downward bias.
The change from wholesale to retail inflation as an anchor means that the weightage of diesel in inflation has decreased
Lower fuel subsidy payouts might restrict gross fiscal deficit in FY15.
From the stock perspective, though, even as all the 10 analysts polled by Bloomberg have a 'buy' recommendation on FRL, their target price of Rs 535 suggest most of the positives are already priced in.
.jpg)
Bank has cited trend of global easing and weak growth
New initiatives expected to bear fruit by middle of 2015
Tomorrow's review could also turn out be the last policy anchored by Rajan if the proposed Monetary Policy Committee (MPC) is put in place before the next review due on August 9.
There would be a short period of turmoil in 2015 but real returns are likely to be positive.
The operating profit growth rate of mobile service providers is expected to double in next two years buoyed by increase in call rates and clarity in policy, credit rating agency CRISIL has said.
Encouragingly, the recovery also appears to be becoming broad-based
India imported 967 tonnes of gold in 2014-15.
Sinha says many fund houses not abiding by rules on minimum number of investors, awareness funds
Market experts believe the retreat is because of uncertainty.
These have always been pro-cyclical bets but new banks could erode RoEs.
Why India is an FDI magnet. The country satisfies several reconditions to attract FDI.
In the April-June period, bond yields rose by 30 bps.
The Sensex has slid 18.5 per cent from its January 2015 peak.
Brokerages expect revenue growth at a 7-quarter high but profitability may disappoint.
Experts feel oil prices will remain volatile with an upward bias.
The Nifty and Sensex traded close to their respective all-time highs.
Indian Economy poised for growth, say experts.
For the first time since 2008, first quarter of 2014 (Jan-March) saw signing of 10 mega-contracts worth $100 million in ACV.
The Reserve Bank of India (RBI) is expected to keep policy rates unchanged at a six-weekly rate review on Tuesday, ending a year-long cutting cycle as it focuses instead on underpinning the plunging currency.
After last Monday's massive fall in the Indian markets, a lot of quality stocks have fallen significantly.
Financials were among the top losers along with Sun Pharma and index heavyweight Reliance Industries
About 48.5 million shares, or 20 per cent of the shares on offer, are reserved for retail investors
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
Sun Pharma expects synergy benefits by next fiscal.
Strong refining and petrochemical margins seen boosting consolidated net by up to 6%
HNI equity folios up 46% in the first half of FY15.
TCS kicked-off the Q1FY17 earnings season for information technology companies on Thursday.
Major global indices like CAC 40, DAX Shanghai Composite, Hang Seng, Nikkei, Straits Times, Sensex, Nifty have lost 1% - 10% in a week
Valuation-wise, the markets look more attractive now
This works only for longer-tenured ones such as income funds, as the element of interest rate risk is reduced.
Exports to Europe shrank by near 2 per cent in the 11 months.
The 30-share Sensex ended down 556 points at 27,886 and the 50-share Nifty ended down 158 points at 8,444.
With cash -- the primary medium of exchange -- all but disappearing, it is now unlikely that the expected fillip to demand on account of a good monsoon and proceeds from the Seventh Pay Commission payout will materialise.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances